Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Prionics is a world leader in the development and manufacture of veterinary diagnostic solutions, specializing in farm animal health. Founded in 1997 as a spin-off from the University of Zurich, the company rose to global prominence by developing the first rapid test for Bovine Spongiform Encephalopathy (BSE), which became the gold standard during the 'Mad Cow Disease' crisis. Its extensive product portfolio, marketed under the PrioCHECK brand, includes validated diagnostic kits for major infectious diseases such as Foot-and-Mouth Disease, Tuberculosis, and Swine Fever. In 2014, Prionics was acquired by Life Technologies, which was subsequently integrated into Thermo Fisher Scientific. Today, Prionics operates as a key brand within Thermo Fisher's animal health division, providing critical tools for disease surveillance and food safety worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Prionics.